553 Results

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Sadelain
    Sadelain
  3. Van Den Brink
    Van Den Brink
  4. Levine
    Levine
  5. Scheinberg
    Scheinberg
  6. Hanash
    Hanash
  7. Giralt
    Giralt
  8. Palomba
    Palomba
  9. Sawyers
    Sawyers
  10. Tsai
    Tsai

Groups

  1. Department of Medicine (553)
  2. GSK Faculty (553)
  3. Hematologic Malignancies, Division of (553)
  4. Sloan Kettering Institute Postdocs (553)
  5. Center for Hematologic Malignancies (491)
  6. Executive Committee, Center for Hematologic Malignancies (309)
  7. Human Oncology and Pathogenesis Program (309)
  8. Sloan Kettering Institute Faculty (282)
  9. Tow Center for Developmental Oncology (TCDO) (243)
  10. Hematologic Malignancies Research (208)
  1. "Meeting abstract"
  2. "Sloan Kettering Institute Postdocs"
  3. "GSK Faculty"
  4. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (553)
Groups
  1. Department of Medicine (553)
  2. GSK Faculty (553)
  3. Hematologic Malignancies, Division of (553)
  4. Sloan Kettering Institute Postdocs (553)
  5. Center for Hematologic Malignancies (491)
  6. Executive Committee, Center for Hematologic Malignancies (309)

More Groups

People
  1. Marcel Van Den Brink (90)
  2. Omar Abdel-Wahab (86)
  3. Ross Levine (81)
  4. Michel Sadelain (79)
  5. David Scheinberg (46)
  6. Alan Hanash (43)

More People

Years
  1. 2024 (2)
  2. 2023 (62)
  3. 2022 (53)
  4. 2021 (35)
  5. 2020 (56)
  6. 2019 (52)

More Years

Publications
  1. Blood (251)
  2. Cancer Research (62)
  3. Journal of Clinical Oncology (51)
  4. Biology of Blood and Marrow Transplantation (30)
  5. Molecular Therapy (23)
  6. Journal for ImmunoTherapy of Cancer (13)

More Publications

Publishers
  1. American Society of Hematology (251)
  2. American Association for Cancer Research (75)
  3. Elsevier Inc. (63)
  4. American Society of Clinical Oncology (51)
  5. Nature Publishing Group (30)
  6. Biomed Central Ltd (13)

More Publishers

Results (553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of tumor microenvironment derived NRG1 in androgen resistance: Implications for a novel prostate cancer treatment strategy
    Meeting Abstract

    Shinder, B.; Mao, N.; Salsabeel, N.; Zhang, Z.; Sawyers, C. L.; Carver, B. S.
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Comprehensive immunogenomic evaluation of patients undergoing consolidative cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with immune checkpoint blockade
    Meeting Abstract

    Reese, S.; Yarlagadda, V.; Wu, C. Y.; Kuo, F.; Tang, C.; Jiang, H.; Vuong, L. H.; Eismann, L.; Motzer, R.; Voss, M. H.; more...
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Fong, C. J.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D. R.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; Mastrogiacomo, B.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • A pro-inflammatory gene signature characterizes a better risk aged AML patient group in ECOG-ACRIN Cancer Research Group's clinical trial E3999
    Meeting Abstract

    Neelamraju, Y.; Rapaport, F.; Gandara, J. A.; Dunham, N.; Fan, H.; Lee, T.; Prajapati, S.; Sheridan, C.; Wang, L.; Cripe, L. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Mutant p53 drives the development of myelodysplastic syndromes via dysregulating pre-mRNA splicing in hematopoietic stem and progenitor cells
    Meeting Abstract

    Barajas, S.; Chen, S.; Vemula, S.; Yang, Y.; Simpson, E.; Cai, W.; Xiao, S.; Chen, H.; Halene, S.; Sukhanova, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • GLUT1 overexpression enhances 19-28z CAR-T cell expansion and metabolic fitness
    Meeting Abstract

    Shi, Y.; Kotchetkov, I. S.; Hanina, S. A.; Sadelain, M.
    Blood (2023)

    Fulltext@MSK | Save
  • Use of a tissue-targeting recombinant human interleukin-22 fusion molecule (F-652) for the treatment of advanced refractory lower GI acute GVHD
    Meeting Abstract

    Satta, T.; Papadopoulos, E. B.; Gyurkocza, B.; Susman, P.; Singh, A.; Calafiore, M.; Giralt, S. A.; Perales, M. A.; Chen, J.; Li, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Genetic alterations of follicular lymphoma can predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Fregonese, B.; Seshan, V.; Hajj, C.; Cederquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save